A Phase I Study of GFH312 in Healthy Chinese Subjects

Status Completed

Clinical Trial Summary

The aim of this study was to evaluate the pharmacokinetic profile and observe the safety of GFH312 after single and multiple administrations in healthy Chinese subjects.

Clinical Trial Description

This study was planned to enroll about 26 healthy subjects, subjects were planned to receive single administration of 100 mg GFH312, single administration of 200 mg GFH312, or multiple administrations of 120 mg GFH312, as well as their matching placebo. Subjects were randomized in 3:1 ratio in the single dose cohorts and in 4:1 ratio in the multiple dose cohort. ;

Study Design

Related Conditions & MeSH terms

Healthy Volunteer

Clinical Trial Details

NCT number	NCT05991362
Study type	Interventional
Source	Genfleet Therapeutics (Shanghai) Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	November 29, 2022
Completion date	May 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06326723` - Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects	Phase 1
Recruiting	`NCT00001367` - Diagnosis and History Study of Patients With Different Neurological Conditions
Completed	`NCT02699710` - Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects	Phase 1
Completed	`NCT02231892` - Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study	N/A
Not yet recruiting	`NCT06441916` - Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions	Phase 1
Completed	`NCT03771586` - A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects	Phase 1
Not yet recruiting	`NCT06337422` - Bioequivalence Study of Generic Celecoxib 200 mg Capsules	Phase 1
Completed	`NCT03302182` - Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects	Phase 1
Completed	`NCT05049343` - Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants	Phase 1
Recruiting	`NCT01629108` - Normal Values in Hearing and Balance Testing
Completed	`NCT02947854` - Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant	Phase 1
Completed	`NCT02534870` - Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects	Phase 1
Completed	`NCT02224053` - Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers	Phase 1
Completed	`NCT01711762` - A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers	Phase 1
Completed	`NCT01676584` - A Study of Single Dose RO6811135 in Healthy Volunteers	Phase 1
Completed	`NCT01697436` - A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets	Phase 1
Completed	`NCT01684891` - A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers	Phase 1
Completed	`NCT02547259` - Influence of Emotion in a Test Run Forgetfulness	N/A
Completed	`NCT01433575` - A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers	Phase 1
Completed	`NCT01591850` - A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers	Phase 1